Area of research
Psychiatry and Mental health · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Dementia and Cognitive Impairment Research, Blood Pressure and Hypertension Studies, Nutritional Studies and Diet, and Health Systems, Economic Evaluations, Quality of Life.
Consensus-Harmonized Neuropsychological Assessment for Vascular Cognitive Impairment and Dementia
A critical review and classification of dementia risk assessment tools to inform dementia risk reduction
Hypertension and Mild Cognitive Impairment: State-of-the-Art Review
Contrast Sensitivity, Visual Field, Color Vision, Motion Perception, and Cognitive Impairment: A Systematic Review
A single risk assessment for the most common diseases of ageing, developed and validated on 10 cohort studies
Use of Antihypertensives, Blood Pressure, and Estimated Risk of Dementia in Late Life
Orthostatic Hypotension, Hypertension Treatment, and Cardiovascular Disease
Reducing the Risk of Cognitive Decline and Dementia: WHO Recommendations
Blood pressure lowering and prevention of dementia: an individual patient data meta-analysis
Dementia Risk Scores and Their Role in the Implementation of Risk Reduction Guidelines
Risk factors common to leading eye health conditions and major non-communicable diseases: a rapid review and commentary
Evaluation of High Cholesterol and Risk of Dementia and Cognitive Decline in Older Adults Using Individual Patient Meta-Analysis
Development of the First WHO Guidelines for Risk Reduction of Cognitive Decline and Dementia: Lessons Learned and Future Directions
Association of anthropometry and weight change with risk of dementia and its major subtypes: A meta‐analysis consisting 2.8 million adults with 57 294 cases of dementia
Effects of Intensive Blood Pressure Treatment on Orthostatic Hypotension
Air Pollution and Dementia: A Systematic Review
Investigation of antihypertensive class, dementia, and cognitive decline
Association Between More Intensive vs Less Intensive Blood Pressure Lowering and Risk of Mortality in Chronic Kidney Disease Stages 3 to 5
Type 2 Diabetes as a Risk Factor for Dementia in Women Compared With Men: A Pooled Analysis of 2.3 Million People Comprising More Than 100,000 Cases of Dementia
No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over
Subgroup and per-protocol analyses from the Hypertension in the Very Elderly Trial
The clock drawing test, mortality, incident cardiovascular events and dementia
Treating hypertension in the very elderly—benefits, risks, and future directions, a focus on the hypertension in the very elderly trial
Does White Coat Hypertension Require Treatment Over Age 80?
Kidney function in the very elderly with hypertension: data from the hypertension in the very elderly (HYVET) trial